Efficacy and safety of jinlida granule in the treatment of diabetic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Qi Yong, Yunxi Xu, Peiying Zhang, Hua Bai, Chao Xu, Hejiang Ye · 2026
Read Efficacy and safety of jinlida granule in the treatment of diabetic kidney disease: a systematic review and meta-analysis of randomized controlled trials by Qi Yong, Yunxi Xu, Peiying Zhang, Hua Bai, Chao Xu, Hejiang Ye (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272490.txt.
Description
Qi Yong and colleagues pooled trial evidence in 2026 on Jinlida granule, a plant based Chinese medicine, for diabetic kidney disease. This kidney damage is a common result of diabetes and a leading cause of kidney failure. The question was whether adding Jinlida helps beyond usual care.
Twelve randomized trials with 1,341 patients were found in Chinese and English databases. Patients given Jinlida showed lower blood creatinine, lower urea, and less protein lost in urine, along with better blood sugar control. Harm rates were similar between groups. Results varied a lot between trials, and bias risk was not low. The authors say larger and better trials are needed before firm advice is possible.
Catalog record
| CREATOR | Qi Yong, Yunxi Xu, Peiying Zhang, Hua Bai, Chao Xu, Hejiang Ye |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |